These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17162363)

  • 1. Mechanisms of dyslipoproteinemias in systemic lupus erythematosus.
    Borba EF; Carvalho JF; Bonfá E
    Clin Dev Immunol; 2006; 13(2-4):203-8. PubMed ID: 17162363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.
    Borba EF; Bonfá E
    Lupus; 1997; 6(6):533-9. PubMed ID: 9256312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus and "lupus dyslipoproteinemia".
    de Carvalho JF; Bonfá E; Borba EF
    Autoimmun Rev; 2008 Jan; 7(3):246-50. PubMed ID: 18190886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus.
    Chung CP; Oeser A; Solus J; Avalos I; Gebretsadik T; Shintani A; Linton MF; Fazio S; Stein CM
    J Rheumatol; 2007 Sep; 34(9):1849-54. PubMed ID: 17659756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus.
    Sarkissian T; Beyene J; Feldman B; McCrindle B; Silverman ED
    Arthritis Rheum; 2007 Feb; 56(2):631-8. PubMed ID: 17265498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of dyslipidemia in children and adolescents with systemic lupus erythematosus.
    Ardoin SP; Sandborg C; Schanberg LE
    Lupus; 2007; 16(8):618-26. PubMed ID: 17711898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of autoimmune antibodies anti-lipoprotein lipase, anti-low density lipoprotein, and anti-oxidized low density lipoprotein on lipid metabolism and atherosclerosis in systemic lupus erythematosus.
    Fesmire J; Wolfson-Reichlin M; Reichlin M
    Rev Bras Reumatol; 2010; 50(5):539-51. PubMed ID: 21125190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies.
    Hahn BH; McMahon M
    Lupus; 2008 May; 17(5):368-70. PubMed ID: 18490409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?
    Karp I; Abrahamowicz M; Fortin PR; Pilote L; Neville C; Pineau CA; Esdaile JM
    Arthritis Rheum; 2008 Feb; 59(2):169-75. PubMed ID: 18240259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review on anti-lipoprotein lipase antibodies.
    Rodrigues CE; Bonfá E; Carvalho JF
    Clin Chim Acta; 2010 Nov; 411(21-22):1603-5. PubMed ID: 20673827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of lipid abnormalities in children with new-onset systemic lupus erythematosus.
    Tyrrell PN; Beyene J; Benseler SM; Sarkissian T; Silverman ED
    J Rheumatol; 2007 Oct; 34(10):2112-9. PubMed ID: 17787042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of dyslipoproteinemia in Thai patients with systemic lupus erythematosus.
    Siripaitoon B; Osiri M; Vongthavaravat V; Akkasilpa S; Deesomchok U
    Lupus; 2004; 13(12):961-8. PubMed ID: 15645754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in lipid profile between flare and remission of patients with systemic lupus erythematosus: a prospective study.
    Urquizu-Padilla M; Balada E; Chacon P; Pérez EH; Vilardell-Tarrés M; Ordi-Ros J
    J Rheumatol; 2009 Aug; 36(8):1639-45. PubMed ID: 19531751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of association between type I hyperlipoproteinemia and systemic lupus erythematosus (SLE). Effects of steroid treatment.
    Pauciullo P; De Simone B; Rubba P; Mancini M
    J Endocrinol Invest; 1986 Dec; 9(6):517-20. PubMed ID: 3571855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body composition, lipid and lipoprotein levels in childhood-onset systemic lupus erythematosus.
    Lilleby V; Haugen M; Mørkrid L; Frey Frøslie K; Holven KB; Førre O
    Scand J Rheumatol; 2007; 36(1):40-7. PubMed ID: 17454934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease complications in systemic lupus erythematosus.
    Torres A; Askari AD; Malemud CJ
    Biomark Med; 2009 Jun; 3(3):239-52. PubMed ID: 20477476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease.
    Escárcega RO; García-Carrasco M; Fuentes-Alexandro S; Jara LJ; Rojas-Rodriguez J; Escobar-Linares LE; Cervera R
    Autoimmun Rev; 2006 Nov; 6(1):48-53. PubMed ID: 17110317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein functionality in systemic lupus erythematosus.
    Ganjali S; Shirmohammadi L; Read MI; Sahebkar A
    Semin Arthritis Rheum; 2020 Aug; 50(4):769-775. PubMed ID: 32531506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus.
    Tseng JC; Lu LY; Hu RJ; Kau CK; Cheng HH; Lin PR; Sun CW; Liang HT; Lam HC; Tai MH
    J Microbiol Immunol Infect; 2007 Feb; 40(1):50-5. PubMed ID: 17332907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families.
    Kristjansdottir H; Saevarsdottir S; Gröndal G; Alarcón-Riquelme ME; Erlendsson K; Valdimarsson H; Steinsson K
    Arthritis Rheum; 2008 Dec; 58(12):3865-72. PubMed ID: 19035512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.